Table 5 MG related health care resource utilization (HCRU) in the DMG dataset in overall study population and different subgroups.

From: The economic burden of Myasthenia gravis from the patient´s perspective and reflected in German claims data

MG related HCRU per patient

overall n = 1,660

oMG n = 388

gMG n = 1,272

SMD1

No MG-related treatment n = 221

Standard treatment n = 1,256

Intensified treatment n = 169

SMD2

EOMG n = 686

LOMG n = 851

SMD3

Doctor visits per year, mean (SD)

5.2 (6.9)

3.9 (3.3)

5.6 (7.6)

− 0.27

2.8 (5.5)

4.8 (5.7)

10.2 (12.1)

− 0.58

4.9 (7.2)

5.3 (6.7)

− 0.05

 Median (IQR)

4.0 (2.0, 6.0)

4.0 (2.0, 4.0)

4.0 (2.0, 6.0)

 

2.0 (1.0, 4.0)

4.0 (2.0, 5.0)

6.0 (4.0, 12.0)

 

4.0 (2.0, 5.3)

4.0 (2.0, 6.0)

 

 Unknown

100

18

82

 

31

59

8

 

30

43

 

Hospital stays during past 12 months, mean (SD)

0.9 (3.5)

0.4 (1.0)

1.0 (3.9)

− 0.22

0.4 (1.1)

0.5 (3.4)

3.1 (4.2)

− 0.69

0.8 (2.3)

0.9 (4.4)

− 0.01

 Median (IQR)

0.0 (0.0, 1.0)

0.0 (0.0, 0.0)

0.0 (0.0, 1.0)

 

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

2.0 (1.0, 4.0)

 

0.0 (0.0, 1.0)

0.0 (0.0, 1.0)

 

 Unknown

418

112

306

 

61

335

21

 

133

232

 

ER visits during past 12 months, mean (SD)

0.2 (2.5)

0.4 (5.0)

0.2 (0.8)

0.06

0.6 (6.6)

0.1 (0.7)

0.5 (0.9)

− 0.47

0.3 (3.7)

0.1 (0.4)

0.09

 Median (IQR)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

 

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

0.0 (0.0, 1.0)

 

0.0 (0.0, 0.0)

0.0 (0.0, 0.0)

 

 Unknown

520

134

386

 

76

389

50

 

172

286

 
  1. 1 Comparing gMG and oMG.
  2. 2 Comparing standard and intensified treatment.
  3. 3 Comparing EOMG and LOMG.